Exact Mass: 404.06537360000004

Exact Mass Matches: 404.06537360000004

Found 47 metabolites which its exact mass value is equals to given mass value 404.06537360000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-D-galactose 4-O-sulfate

C12H20O13S (404.06245900000005)

Urolithin A-3-O-glucuronide

3,4,5-trihydroxy-6-({8-hydroxy-6-oxo-6H-benzo[c]chromen-3-yl}oxy)oxane-2-carboxylic acid

C19H16O10 (404.0743436)

Urolithin A glucuronide is a biomarker of nut consumption in urine.

Urolithin A-8-O-glucuronide

(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-({8-hydroxy-6-oxo-6H-benzo[c]chromen-3-yl}oxy)oxane-2-carboxylic acid

C19H16O10 (404.0743436)

Urolithin A-8-O-glucuronide is a conjugate of Urolithin A and glucuronide. A glucuronide, also known as glucuronoside, is any substance produced by linking glucuronic acid to another substance via a glycosidic bond. The glucuronides belong to the glycosides. Glucuronidation, the conversion of chemical compounds to glucuronides, is a method that animals use to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Enzymes that cleave the glycosidic bond of a glucuronide are called glucuronidases. (Wikipedia)

Urolithin a 3-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({8-hydroxy-6-oxo-6H-benzo[c]chromen-3-yl}oxy)oxane-2-carboxylic acid

C19H16O10 (404.0743436)

Urolithin a 8-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({3-hydroxy-6-oxo-6H-benzo[c]chromen-8-yl}oxy)oxane-2-carboxylic acid

C19H16O10 (404.0743436)

Iolopride

3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide, (R)-isomer, 125I labeled

C15H21IN2O3 (404.05968659999996)

D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists

5-Chloropropacin

C20H17ClO7 (404.0662762)

2-{[4-methyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(4-sulfamoylphenyl)acetamide

C16H16N6O3S2 (404.0725266)

3-Formyl-6-(3-formyl-2,4-dihydroxy-6-methyl-benzoyloxymethyl)-2,4-dihydroxy-benzoesaeure-methylester|3-formyl-6-(3-formyl-2,4-dihydroxy-6-methyl-benzoyloxymethyl)-2,4-dihydroxy-benzoic acid methyl ester|methyl barbatolate

3-Formyl-6-(3-formyl-2,4-dihydroxy-6-methyl-benzoyloxymethyl)-2,4-dihydroxy-benzoesaeure-methylester|3-formyl-6-(3-formyl-2,4-dihydroxy-6-methyl-benzoyloxymethyl)-2,4-dihydroxy-benzoic acid methyl ester|methyl barbatolate

C19H16O10 (404.0743436)

Urolithin a-O-glucuronide

3,4,5-trihydroxy-6-({8-hydroxy-6-oxo-6H-benzo[c]chromen-3-yl}oxy)oxane-2-carboxylic acid

C19H16O10 (404.0743436)

N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4-quinazolinamine

C18H14ClFN4O4 (404.06875660000003)

tert-Butyl 3-((3-iodopyridin-2-yloxy)methyl)-pyrrolidine-1-carboxylate

C15H21IN2O3 (404.05968659999996)

m-cresol purple, sodium salt

C21H17NaO5S (404.06943520000004)

NVP-ACC789

C21H17BrN4 (404.0636502)

Metacresol purple sodium salt

C21H17NaO5S (404.06943520000004)

6-BROMO-4-(2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE

C21H17BrN4 (404.0636502)

7-BROMO-4-(2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO[1,2-B]PYRAZOL-3-YL)QUINOLINE

C21H17BrN4 (404.0636502)

3-(1H,1H-Nonafluoropentyl)-4-methylcyclopentane-1,1-dicarboxylic acid

C13H13F9O4 (404.0670086)

k-ras(g12c) inhibitor 6

C17H22Cl2N2O3S (404.07281220000004)

Cresol red

C21H17NaO5S (404.06943520000004)

Urolithin A glucuronide

C19H16O10 (404.0743436)

(2r)-2-Amino-3,3,3-Trifluoro-N-Hydroxy-2-{[(4-Phenoxyphenyl)sulfonyl]methyl}propanamide

C16H15F3N2O5S (404.06537360000004)

3-O-(3,6-Anhydro-alpha-D-galactopyranosyl)-beta-D-galactopyranose 4-sulfate

C12H20O13S (404.06245900000005)

Isourolithin A glucuronide

C19H16O10 (404.0743436)

N-(4-bromophenyl)-4-(2-methoxyphenyl)-1-piperidinecarbothioamide

C19H21BrN2OS (404.05578760000003)

1-S-[3-hydroxy-3-methyl-N-(sulfonatooxy)pentanimidoyl]-1-thio-beta-D-glucopyranose

C12H22NO10S2- (404.0685092)

Urolithin a 8-glucuronide

C19H16O10 (404.0743436)

urolithin A 3-O-glucuronide

C19H16O10 (404.0743436)

A member of the class of benzochromenones that is urolithin A in which the phenolic hydrogen at position 3 has been replaced by a beta-D-glucuronosyl group.

urolithin A 8-O-glucuronide

C19H16O10 (404.0743436)

A member of the class of benzochromenones that is urolithin A in which the phenolic hydrogen at position 8 has been replaced by a beta-D-glucuronosyl group.

glucocleomin(1-)

C12H22NO10S2 (404.0685092)

A hydroxy-alkylglucosinolate that is 2-methylbutylglucosinolate which has been hydroxylated at the 2-position of the 2-methylbutyl chain.

(2r,3r)-6-chloro-3-(4-hydroxy-3-methoxyphenyl)-5-methoxy-2-methyl-2h,3h-[1,4]dioxino[2,3-h]chromen-9-one

C20H17ClO7 (404.0662762)

5,13,17-trihydroxy-12-(hydroxymethyl)-4-(methoxymethyl)-7-methyl-2,10,16-trioxatetracyclo[9.7.0.0³,⁸.0¹⁴,¹⁸]octadeca-1(11),3(8),4,6,12,14(18)-hexaene-9,15-dione

C19H16O10 (404.0743436)

3-{[(5,7-dihydroxy-6-methyl-1-oxo-3h-2-benzofuran-4-yl)oxy]carbonyl}-2-hydroxy-6-methoxy-4-methylbenzoic acid

C19H16O10 (404.0743436)

6-hydroxy-5,7,12,13,14-pentamethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

C19H16O10 (404.0743436)